SANDUPHQ exchange filings, corporate actions and results
4 Sep 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
20 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
19 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Registered With The Company/RTABSE filing · raw filing ↗
Sandu Pharmaceuticals Ltd - 524703 - Annual General Meeting To Be Held On 11Th September 2026 At 04:30 Pm Through Video Conferencing ('VC')/ Other Audio Visual Means (QAVM)BSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
13 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Approval Of Material Related Party Transactions Subject To Approval Of ShareholdersBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Statement Of Deviation And Utilisation Of Funds For Q Ended 30.06.2026BSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Intimation About The Date Of The Annual General MeetingBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Intimation About The Record DateBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Intimation About Book Closure For AGMBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Outcome And Results Of The Board Meeting Dated 11.08.2026 Was Submitted On Time But Inadvertently No Digital Signature Was Affixed On The Covering Letter Further There Is No Change In The Contents Of The OutcomeBSE filing · raw filing ↗
11 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹16 Cr (−1.9% YoY), PAT ₹0 Cr (+2.2% YoY)BSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Outcome Of The Board MeetingBSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.08.2026BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
